Skip to content
Thread Labs logo — Your unified source for comprehensive investment intelligenc...

Thread Labs

Your unified source for comprehensive investment intelligence and data, catering to hedge funds, private equity, and asset managers.

Founded 2020 11-50 employees Non Equity Assistance Finance, Information Technology

General Information

Company Name Thread Labs
Founded Year 2020
Employees 11-50
Industries Finance, Information Technology
Funding Stage Non Equity Assistance
Social

BounceWatch is an independent company data service, not affiliated with Thread Labs. To contact Thread Labs, visit threadlabs.co.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Thread Labs compare?

A PDF of Thread Labs and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Thread Labs soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Thread Labs

Thread Labs is a startup founded in 2020 that offers a unified source for comprehensive investment intelligence and data. Targeting clients within the finance and information technology industries, the company caters to hedge funds, private equity, and asset managers. Their latest investment, a non-equity assistance investment at 11 November 2021, was secured from Catapult: Kickstarter. Thread Labs' slogan, "Your unified source for comprehensive investment intelligence and data, catering to hedge funds, private equity, and asset managers," encapsulates their commitment to providing investment research insights and data for their target market. With a focus on providing valuable insights and data, Thread Labs is positioned as a strong contender in the investment intelligence and data space.

Business keywords: investment intelligence, hedge funds, private equity, investment research, insights, financial data, investment platform

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Non Equity Assistance Undisclosed 1
Catapult: Kickstarter
11 Nov 2021

Thread Labs Alternatives & Competitors

View All Alternatives
Thread Labs vs

Making software an asset, not an expense.

1 employees
Finance, Financial Services
Thread Labs vs
Money.net
Money.net United States

The multi-asset, real-time financial data & analytics platform for investors

Seed
21 employees
Analytics, Enterprise Software
Thread Labs vs
Allocator
Allocator United Kingdom

The leading intelligence platform for institutional investors in funds

35 employees
Analytics, Finance

FAQ About Thread Labs

Your unified source for comprehensive investment intelligence and data, catering to hedge funds, private equity, and asset managers.
Thread Labs was founded in 2020.
Thread Labs operates in Finance and Information Technology. Its work centres on investment intelligence, hedge funds, private equity and investment research.
Thread Labs has approximately 11-50 employees.
Thread Labs has completed 1 funding round. The latest funding stage is Non Equity Assistance.
Top alternatives and competitors to Thread Labs include Messer Financial Software, Money.net, Allocator, Enfusion, ClearMacro. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Thread Labs and Messer Financial Software are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Thread Labs, https://bouncewatch.com/company/thread-labs, updated 2 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout